Ensign Peak Advisors, Inc Viking Therapeutics, Inc. Transaction History
Ensign Peak Advisors, Inc
- $51.2 Billion
- Q1 2025
A detailed history of Ensign Peak Advisors, Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 172,890 shares of VKTX stock, worth $6.56 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
172,890
Previous 412,656
58.1%
Holding current value
$6.56 Million
Previous $16.6 Million
74.86%
% of portfolio
0.01%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding VKTX
# of Institutions
451Shares Held
67.8MCall Options Held
7.72MPut Options Held
3.25M-
Vanguard Group Inc Valley Forge, PA10.2MShares$385 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$229 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$143 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.25MShares$123 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$119 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.91B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...